Lyell Immunopharma (LYEL) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-3.6
-2.46
-1.31
-0.17

Details

Expected EPS
-3.6
Actual EPS
-1.86
Surprise EPS
1.74
Surprise Percent
+48.33%

Description

Lyell Immunopharma (LYEL) has reported earnings of -1.86 per share for Q2 2025.

0 Comments

Share your thoughts